ArticleMolecules (Basel, Switzerland)2021

Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.

Sumera Zaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.